ExodusPoint Capital Management’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-84,740
| Closed | -$242K | – | 2002 |
|
|
2024
Q3 | $242K | Buy |
+84,740
| New | +$242K | ﹤0.01% | 1312 |
|
|
2023
Q4 | – | Sell |
-185,221
| Closed | -$345K | – | 2045 |
|
|
2023
Q3 | $345K | Buy |
+185,221
| New | +$345K | ﹤0.01% | 1334 |
|
|
2022
Q4 | – | Sell |
-20,528
| Closed | -$32K | – | 2136 |
|
|
2022
Q3 | $32K | Sell |
20,528
-36,266
| -64% | -$56.5K | ﹤0.01% | 1768 |
|
|
2022
Q2 | $87K | Sell |
56,794
-453,164
| -89% | -$694K | ﹤0.01% | 1705 |
|
|
2022
Q1 | $1.31M | Buy |
509,958
+469,564
| +1,162% | +$1.2M | 0.02% | 937 |
|
|
2021
Q4 | $118K | Buy |
+40,394
| New | +$118K | ﹤0.01% | 1886 |
|
|
2020
Q4 | – | Sell |
-16,867
| Closed | -$100K | – | 2345 |
|
|
2020
Q3 | $100K | Sell |
16,867
-15,715
| -48% | -$93.2K | ﹤0.01% | 1529 |
|
|
2020
Q2 | $87K | Buy |
+32,582
| New | +$87K | ﹤0.01% | 1622 |
|
|
2020
Q1 | – | Sell |
-47,000
| Closed | -$331K | – | 1638 |
|
|
2019
Q4 | $331K | Buy |
+47,000
| New | +$331K | 0.01% | 1046 |
|